Petco Health & Wellness Company, Inc. (WOOF) stock
Close on Nov 18, 2026Market cap $888.34MP/E 27.4Yield –
Earnings
Petco Health & Wellness's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Petco Health & Wellness's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Nov 1, 2026 | Nov 24, 2026Expected | – | – | – | – | – |
| Q2 FY2026ended Aug 1, 2026 | Sep 2, 2026during market hours | $1.50B | 0.0% | $0.13 | – | Release |
| Q1 FY2026ended May 2, 2026 | Jun 3, 2026during market hours | $1.50B | +0.4% | -$0.05 | – | Release |
| Q4 FY2025ended Jan 31, 2026 | Mar 11, 2026during market hours | $1.52B | -2.4% | -$0.01 | – | Release |
| Q3 FY2025ended Nov 1, 2025 | Nov 25, 2025during market hours | $1.50B | -0.7% | $0.03 | – | Release |
| Q2 FY2025ended Aug 2, 2025 | Aug 28, 2025during market hours | $1.50B | -1.3% | $0.05 | – | Release |
| Q1 FY2025ended May 3, 2025 | Jun 5, 2025during market hours | $1.49B | -0.4% | -$0.04 | – | Release |
| Q4 FY2024ended Feb 1, 2025 | Mar 26, 2025during market hours | $1.55B | -8.7% | -$0.05 | – | Release |
| Q3 FY2024ended Nov 2, 2024 | Dec 5, 2024during market hours | $1.51B | +1.3% | -$0.06 | -$0.02 | Release |
| Q2 FY2024ended Aug 3, 2024 | Sep 10, 2024during market hours | $1.52B | -0.7% | -$0.09 | -$0.02 | Release |
| Q1 FY2024ended May 4, 2024 | May 22, 2024before the open | $1.50B | -3.8% | -$0.17 | -$0.04 | Release |
| Q4 FY2023ended Feb 3, 2024 | Mar 13, 2024before the open | $1.70B | – | -$0.08 | $0.02 | Release |
| Q3 FY2023ended Oct 28, 2023 | Nov 29, 2023before the open | $1.49B | -0.7% | -$4.63 | -$0.05 | Release |
| Q2 FY2023ended Jul 29, 2023 | Aug 24, 2023before the open | $1.53B | +3.4% | -$0.05 | $0.06 | Release |
| Q1 FY2023ended Apr 29, 2023 | May 24, 2023before the open | $1.56B | +5.4% | -$0.01 | $0.06 | Release |
| Q3 FY2022ended Oct 29, 2022 | Nov 30, 2022before the open | $1.50B | +7.1% | $0.07 | $0.16 | Release |
| Q2 FY2022ended Jul 30, 2022 | Aug 24, 2022before the open | $1.48B | – | $0.05 | $0.19 | Release |
| Q1 FY2022ended Apr 30, 2022 | May 24, 2022before the open | $1.48B | – | $0.09 | $0.17 | Release |
| Q4 FY2021ended Jan 29, 2022 | Mar 8, 2022before the open | $1.50B | – | $0.11 | $0.28 | Release |
| Q3 FY2021ended Oct 30, 2021 | Nov 18, 2021before the open | $1.40B | – | $0.20 | $0.20 | Release |
| Q2 FY2021ended Jul 31, 2021 | Aug 19, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended May 1, 2021 | May 20, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Jan 30, 2021 | Mar 18, 2021before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Petco Health & Wellness's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net Sales | Q3 FY2026 | +0.4% – +1% | – | New | Sep 2, 2026 |
| Adjusted EBITDAnon-GAAP | Q3 FY2026 | $100.00M – $103.00M | – | New | Sep 2, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $415.00M – $430.00M | $415.00M – $430.00M | Reaffirmed | Sep 2, 2026 |
| Capital Expenditures | FY2026 | $140.00M | $140.00M | Reaffirmed | Sep 2, 2026 |
| Depreciation & Amortization | FY2026 | $200.00M | $200.00M | Raised | Sep 2, 2026 |
| Net Interest Expense | FY2026 | $122.00M | $125.00M | Lowered | Sep 2, 2026 |
| Net Store Closures | FY2026 | 15 – 20 | 15 – 20 | Reaffirmed | Sep 2, 2026 |
Guidance vs results
The last range Petco Health & Wellness gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2026 | Revenue growth | +0.3% | 0% | Below range |
| FY2025 | Revenue growth | -2.8% – -2.5% | -1.21%Σ4Q | Above range |
| Q4 FY2024 | Revenue | $1.55B | $1.55B | Above range |
| Q2 FY2024 | Adjusted EPS | -$0.02 | -$0.02 | Within range |
| Q2 FY2024 | Revenue | $1.53B | $1.52B | Below range |
| Q1 FY2024 | Adjusted EPS | -$0.06 | -$0.04 | Above range |
| Q1 FY2024 | Revenue | $1.50B | $1.50B | Within range |
Guidance history
Every forecast Petco Health & Wellness put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Sep 2, 2026 | Capital Expenditures | FY2026 | $140.00M | Reaffirmed |
| Sep 2, 2026 | Adjusted EBITDA | FY2026 | $415.00M – $430.00M | Reaffirmed |
| Sep 2, 2026 | Adjusted EBITDA | Q3 FY2026 | $100.00M – $103.00M | New |
| Sep 2, 2026 | Net Store Closures | FY2026 | 15 – 20 | Reaffirmed |
| Sep 2, 2026 | Net Interest Expense | FY2026 | $122.00M | Lowered |
| Sep 2, 2026 | Depreciation & Amortization | FY2026 | $200.00M | Raised |
| Sep 2, 2026 | Net Sales | Q3 FY2026 | +0.4% – +1% | New |
| Jun 3, 2026 | Capital Expenditures | FY2026 | $140.00M | Reaffirmed |
| Jun 3, 2026 | Adjusted EBITDA | FY2026 | $415.00M – $430.00M | Reaffirmed |
| Jun 3, 2026 | Adjusted EBITDA | Q2 FY2026 | $110.00M – $112.00M | New |
| Jun 3, 2026 | Net Interest Expense | FY2026 | $125.00M | Lowered |
| Jun 3, 2026 | Depreciation & Amortization | FY2026 | $200.00M | Raised |
| Jun 3, 2026 | Net Sales | Q2 FY2026 | +0.3% | New |
| Mar 11, 2026 | Capital Expenditures | FY2026 | $140.00M | New |
| Mar 11, 2026 | Adjusted EBITDA | FY2026 | $415.00M – $430.00M | New |
| Mar 11, 2026 | Adjusted EBITDA | Q1 FY2026 | $92.00M – $94.00M | New |
| Mar 11, 2026 | Net Store Closures | FY2026 | 15 – 20 | New |
| Mar 11, 2026 | Net Interest Expense | FY2026 | $125.00M | New |
| Mar 11, 2026 | Depreciation & Amortization | FY2026 | $200.00M | Raised |
| Nov 25, 2025 | Capital Expenditures | FY2025 | $125.00M – $130.00M | New |
| Nov 25, 2025 | Adjusted EBITDA | FY2025 | $395.00M – $397.00M | New |
| Nov 25, 2025 | Adjusted EBITDA | Q4 FY2025 | $93.00M – $95.00M | New |
| Nov 25, 2025 | Net interest expense | FY2025 | $125.00M | New |
| Nov 25, 2025 | Depreciation & Amortization | FY2025 | $200.00M | Raised |
| Nov 25, 2025 | Net Sales | FY2025 | -2.8% – -2.5% | New |
| Aug 28, 2025 | Capital Expenditures | FY2025 | $125.00M – $130.00M | Reaffirmed |
| Aug 28, 2025 | Adjusted EBITDA | Q3 FY2025 | $92.00M – $94.00M | New |
| Aug 28, 2025 | Adjusted EBITDA | FY2025 | $385.00M – $395.00M | Raised |
| Aug 28, 2025 | Net Store Closures | FY2025 | 25 | Raised |
| Aug 28, 2025 | Net interest expense | FY2025 | $130.00M | Lowered |
| Aug 28, 2025 | Depreciation & Amortization | FY2025 | $200.00M | Raised |
| Jun 5, 2025 | Capital Expenditures | FY2025 | $125.00M – $130.00M | Lowered |
| Jun 5, 2025 | Adjusted EBITDA | Q2 FY2025 | $92.00M – $94.00M | New |
| Jun 5, 2025 | Adjusted EBITDA | FY2025 | $375.00M – $390.00M | Reaffirmed |
| Jun 5, 2025 | Net interest expense | FY2025 | $130.00M | Lowered |
| Jun 5, 2025 | Depreciation & Amortization | FY2025 | $200.00M | Raised |
| Mar 26, 2025 | Capital expenditures | FY2025 | $130.00M – $140.00M | New |
| Mar 26, 2025 | Adjusted EBITDA | Q1 FY2025 | $82.00M – $83.00M | New |
| Mar 26, 2025 | Adjusted EBITDA | FY2025 | $375.00M – $390.00M | New |
| Mar 26, 2025 | Real estate | FY2025 | -30 – -20 | New |
| Mar 26, 2025 | Net interest expense | FY2025 | $130.00M | New |
| Mar 26, 2025 | Depreciation & amortization | FY2025 | $200.00M | Raised |
| Dec 5, 2024 | Capital Expenditures | FY2024 | $130.00M | Lowered |
| Dec 5, 2024 | Adjusted EBITDA | Q4 FY2024 | $90.00M – $95.00M | New |
| Dec 5, 2024 | Adjusted EPS | Q4 FY2024 | $0.00 – $0.02 | New |
| Dec 5, 2024 | Net interest expense | FY2024 | $140.00M | Lowered |
| Dec 5, 2024 | Net Revenue | Q4 FY2024 | $1.55B | New |
| May 22, 2024 | Capital Expenditures | FY2024 | $140.00M | Reaffirmed |
| May 22, 2024 | Adjusted EBITDA | Q2 FY2024 | $80.00M | New |
| May 22, 2024 | Adjusted EPS | Q2 FY2024 | -$0.02 | New |
| May 22, 2024 | Net interest expense | FY2024 | $145.00M | Reaffirmed |
| May 22, 2024 | Net Revenue | Q2 FY2024 | $1.53B | New |
| Mar 13, 2024 | Capital Expenditures | FY2024 | $140.00M | New |
| Mar 13, 2024 | Adjusted EBITDA | Q1 FY2024 | $70.00M | New |
| Mar 13, 2024 | Adjusted EPS | Q1 FY2024 | -$0.06 | New |
| Mar 13, 2024 | Net interest expense | FY2024 | $145.00M | New |
| Mar 13, 2024 | Net Revenue | Q1 FY2024 | $1.50B | New |
| Nov 29, 2023 | Capital Expenditures | FY2023 | $215.00M – $225.00M | Lowered |
| Nov 29, 2023 | Adjusted EBITDA | FY2023 | $400.00M | Lowered |
| Nov 29, 2023 | Adjusted EPS | FY2023 | $0.08 | Lowered |
| Nov 29, 2023 | Net Revenue | FY2023 | $6.15B – $6.28B | Reaffirmed |
| Aug 24, 2023 | Capital Expenditures | FY2023 | $215.00M – $225.00M | New |
| Aug 24, 2023 | Adjusted EBITDA | FY2023 | $460.00M – $480.00M | Lowered |
| Aug 24, 2023 | Adjusted EPS | FY2023 | $0.24 – $0.30 | Lowered |
| Aug 24, 2023 | Net Revenue | FY2023 | $6.15B – $6.28B | Reaffirmed |
| May 24, 2023 | Capital Expenditures | FY2023 | $225.00M – $250.00M | New |
| May 24, 2023 | Adjusted EBITDA | FY2023 | $520.00M – $540.00M | New |
| May 24, 2023 | Adjusted EPS | FY2023 | $0.40 – $0.48 | New |
| May 24, 2023 | Net Revenue | FY2023 | $6.15B – $6.28B | New |
| Nov 30, 2022 | Capital Expenditures | FY2022 | $250.00M – $275.00M | Lowered |
| Nov 30, 2022 | Adjusted EBITDA | FY2022 | $580.00M – $595.00M | Reaffirmed |
| Nov 30, 2022 | Adjusted Earnings Per Share | FY2022 | $0.75 – $0.79 | Lowered |
| Nov 30, 2022 | net revenue | FY2022 | $5.98B – $6.05B | Reaffirmed |
| Aug 24, 2022 | capital expenditures | FY2022 | $250.00M – $275.00M | Lowered |
| Aug 24, 2022 | Adjusted EBITDA | FY2022 | $580.00M – $595.00M | Lowered |
| Aug 24, 2022 | Adjusted Earnings Per Share | FY2022 | $0.77 – $0.81 | Lowered |
| Aug 24, 2022 | net revenue | FY2022 | $5.98B – $6.05B | Lowered |
| May 24, 2022 | Capital Expenditures | FY2022 | $275.00M – $325.00M | New |
| May 24, 2022 | Adjusted EBITDA | FY2022 | $630.00M – $645.00M | Reaffirmed |
| May 24, 2022 | Adjusted EPS | FY2022 | $0.97 – $1.00 | Reaffirmed |
| May 24, 2022 | Net Revenue | FY2022 | $6.15B – $6.25B | Reaffirmed |
| Mar 8, 2022 | Capital Expenditures | FY2022 | $275.00M – $325.00M | New |
| Mar 8, 2022 | Adjusted EBITDA | FY2022 | $630.00M – $645.00M | New |
| Mar 8, 2022 | Adjusted EPS | FY2022 | $0.97 – $1.00 | New |
| Mar 8, 2022 | Net Revenue | FY2022 | $6.15B – $6.25B | New |
| Nov 18, 2021 | Capital Expenditures | FY2021 | $220.00M – $235.00M | New |
| Nov 18, 2021 | Adjusted EBITDA | FY2021 | $577.00M – $582.00M | New |
| Nov 18, 2021 | Adjusted EPS | FY2021 | $0.86 – $0.88 | New |
| Nov 18, 2021 | Net Revenue | FY2021 | $5.73B – $5.78B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Petco Health & Wellness filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Results
- Update
- Update
- Update
- Update
- Results
- Results
- Update
- Results
- Results
- Update
- Results
See a number that looks wrong?